Introduction: Ventricular dysrhythmias and sudden death are among the most common
complications of cardiac sarcoidosis. The role of electrophysiologic studies with …

Introduction: Cardiac Sarcoidosis (CS) leads to life-threatening dysrhythmias. The role of
electrophysiologic studies (EPS) with radiofrequency ablation (RFA) in this population is …

Background Cardiac Sarcoidosis (CS) can lead to life-threatening ventricular dysrhythmias
and sudden death. Immunosuppressive medications, radiofrequency ablation (RFA), and …

Sarcoidosis is a systemic inflammatory disease of unknown etiology that is characterized by
the formation of noncaseating granulomas and subsequent tissue scarring. It primarily …

BACKGROUND: Management of ventricular tachycardia (VT) is challenging in patients with
cardiac sarcoidosis. OBJECTIVE: The purpose of this study was to assess the response of …

Background—Fatal arrhythmia is commonly observed in cardiac sarcoidosis, but clinical
effects of a systematic treatment approach are still uncertain. This study sought to describe …

Objective: Cardiac involvement in sarcoidosis can present in various ways, with
atrioventricular (AV) block and ventricular arrhythmias being the most common signs …

Background: Cardiac sarcoidosis (CS) is a rare form of arrhythmogenic cardiomyopathy; a
delayed diagnosis can lead to significant consequences. Patients with clinically manifest CS …

Cardiac sarcoidosis (CS) is characterised by a high burden of arrhythmic manifestations and
cardiac electrophysiologists play an important role in both the diagnosis and management of …

Cardiac sarcoidosis (CS) affects less than 5% of patients with pulmonary or systemic
sarcoidosis, but when present is often associated with a spectrum of clinically significant …